FIGR Nasdaq Loan Brokers Financials FY2023βFY2025
Figure Technology Solutions, Inc. had $507M of revenue in fiscal 2025, up 48.7% on the year before.
Last close Β· Oct 23, 2026
$23.19
3.5%Hi! I read Figure Technology Solutions, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+48.7%
Yes. Sales grew 48.7% last year.
Does it make a profit?
26.4%
Yes. It keeps 26.4% of every sale as profit.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
25.8x
One share costs 25.8 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Figure Technology Solutions, Inc. had $507M of revenue in fiscal 2025, up 48.7% on the year before. Its operating margin was 23.2%, up 20.5Β pts: of every 100 in sales, about 23 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Figure Technology Solutions, Inc. made $134M of net profit in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· Figure Technology Solutions, Inc. returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 95.2%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders bought $0.2M and sold $119M of shares on the open market.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.2M
1 insider
Sold, 12 months
$119M
6 insiders
Of sales under plans
18%
$20.8M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Minchung KgilChief Financial Officer | Sold plan | 8,000 | $38.69 | $0.3M | Form 4 |
| Aug 14, 2026 | David Todd StevensChief Capital Officer | Sold plan | 47,650 | $31.39 | $1.5M | Form 4 |
| Aug 12, 2026 | Minchung KgilChief Financial Officer | Sold plan | 4,000 | $30.03 | $0.1M | Form 4 |
| Jul 24, 2026 | Minchung KgilChief Financial Officer | Sold plan | 4,000 | $28.13 | $0.1M | Form 4 |
| Jun 30, 2026 | Minchung KgilChief Financial Officer | Sold plan | 4,000 | $30.03 | $0.1M | Form 4 |
| Jun 24, 2026 | Minchung KgilChief Financial Officer | Sold plan | 4,000 | $27.64 | $0.1M | Form 4 |
| Jun 15, 2026 | Minchung KgilChief Financial Officer | Sold | 9,117 | $30.06 | $0.3M | Form 4 |
| May 26, 2026 | Minchung KgilChief Financial Officer | Sold plan | 8,000 | $35.70 | $0.3M | Form 4 |
| May 20, 2026 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold plan | 2,031 | $36.03 | $0.1M | Form 4 |
| May 19, 2026 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold plan | 14,871 | $37.27 | $0.6M | Form 4 |
| May 14, 2026 | David Todd StevensChief Capital Officer | Sold plan | 47,064 | $42.35 | $2.0M | Form 4 |
| May 13, 2026 | June OuDirector, 10% owner | Sold plan | 35,190 | $38.20 | $1.3M | Form 4 |
| May 13, 2026 | Michael Scott CagneyDirector, 10% owner | Sold plan | 35,190 | $38.20 | $1.3M | Form 4 |
| Apr 29, 2026 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold plan | 56,825 | $31.98 | $1.8M | Form 4 |
| Apr 28, 2026 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold plan | 127,369 | $33.35 | $4.2M | Form 4 |
| Apr 24, 2026 | Minchung KgilChief Financial Officer | Sold plan | 8,000 | $32.25 | $0.3M | Form 4 |
| Apr 15, 2026 | June OuDirector, 10% owner | Sold plan | 67,840 | $35.19 | $2.4M | Form 4 |
| Apr 15, 2026 | Michael Scott CagneyDirector, 10% owner | Sold plan | 67,840 | $35.19 | $2.4M | Form 4 |
| Mar 24, 2026 | Minchung KgilChief Financial Officer | Sold plan | 8,000 | $33.49 | $0.3M | Form 4 |
| Mar 19, 2026 | David Todd StevensChief Capital Officer | Sold plan | 49,708 | $32.02 | $1.6M | Form 4 |
| Mar 10, 2026 | Sachin Chand JaitlyDirector | Sold | 216,713 | $33.64 | $7.3M | Form 4 |
| Feb 18, 2026 | David Todd StevensChief Capital Officer | Sold | 26,057 | $32.00 | $0.8M | Form 4 |
| Dec 10, 2025 | Michael Scott CagneyDirector, 10% owner | Sold | 200,058 | $39.39 | $7.9M | Form 4 |
| Dec 5, 2025 | David K ChaoDirector | Bought | 4,000 | $38.26 | $0.2M | Form 4 |
| Dec 3, 2025 | Minchung KgilChief Financial Officer | Sold | 32,994 | $35.06 | $1.2M | Form 4 |
| Dec 3, 2025 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold | 90,026 | $35.13 | $3.2M | Form 4 |
| Dec 3, 2025 | David Todd StevensChief Capital Officer | Sold | 40,000 | $35.22 | $1.4M | Form 4 |
| Dec 2, 2025 | Minchung KgilChief Financial Officer | Sold | 100,000 | $35.09 | $3.5M | Form 4 |
| Dec 2, 2025 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold | 60,000 | $35.22 | $2.1M | Form 4 |
| Nov 25, 2025 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold | 29,437 | $34.16 | $1.0M | Form 4 |
| Nov 24, 2025 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold | 100,000 | $35.82 | $3.6M | Form 4 |
| Nov 21, 2025 | Michael Scott CagneyDirector, 10% owner | Sold | 250,000 | $34.06 | $8.5M | Form 4 |
| Nov 20, 2025 | Michael Scott CagneyDirector, 10% owner | Sold | 500,000 | $36.22 | $18.1M | Form 4 |
| Nov 18, 2025 | Michael Benjamin TannenbaumChief Executive Officer, Director | Sold | 908,000 | $39.20 | $35.6M | Form 4 |
| Nov 18, 2025 | David Todd StevensChief Capital Officer | Sold | 83,500 | $39.29 | $3.3M | Form 4 |
Can it carry its debts, and how well does it use its money?
KIRA Β· Figure Technology Solutions, Inc. has $641M more cash than debt.
Cash, debt and the ratios that show how comfortably Figure Technology Solutions, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $176M | $290M | $1.2B |
| Debt incl. finance leases | β | $473M | $557M |
| Debt / equity | β | 1.3x | 0.5x |
| Current ratio | β | 1.4x | 2.2x |
| Quick ratio | β | 1.4x | 2.2x |
| Total assets | β | $1.2B | $2.3B |
| Total liabilities | β | $796M | $1.1B |
| Shareholders' equity | $222M | $355M | $1.2B |
| Net debt (β = net cash) | β | $184M | β$641M |
KIRA Β· Its return on capital was 20.0%: every 100 invested in the business earned about 20 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Figure Technology Solutions, Inc. passes 5 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 4 | 5 / 8 |
| Accruals ratio | β | 12.4% | 4.1% |
| Altman Z'' | β | 0.92 | 4.15 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $210M | $341M | $507M |
| Research and development | $49.2M | $62.7M | $64.9M |
| Operating income | β$49.4M | $9.2M | $118M |
| Pretax income | β$52.3M | $22.1M | $114M |
| Income tax | $0.1M | $2.2M | β$20.6M |
| Net income | β$47.9M | $17.2M | $134M |
| Net income to common | β$47.9M | $0.0M | $62.0M |
| Diluted EPS | β$0.93 | $0.00 | $0.44 |
| Diluted shares | 0.05B | 0.07B | 0.14B |
| Cash flow | |||
| Cash from operations | β$33.4M | β$127M | $62.6M |
| Stock-based compensation | $13.5M | $38.7M | $62.4M |
| Share buybacks | $0.0M | $1.0M | $0.0M |
| Dividends and buybacks | $0.0M | $1.0M | $0.0M |
| Balance sheet | |||
| Cash and short-term investments | $176M | $290M | $1.2B |
| Total debt | β | $473M | $557M |
| Current assets | β | $855M | $1.9B |
| Current liabilities | β | $626M | $846M |
| Total assets | β | $1.2B | $2.3B |
| Total liabilities | β | $796M | $1.1B |
| Preferred stock | β | β | $0.0M |
| Shareholders' equity | $222M | $355M | $1.2B |
| Margins | |||
| Operating margin | β23.6% | 2.7% | 23.2% |
| Net margin | β22.9% | 5.0% | 26.4% |
| Returns | |||
| Return on capital | β | 1.5% | 20.0% |
| Return on capital employed | β | 1.7% | 8.0% |
| Return on equity | β21.6% | 6.0% | 16.9% |
| Return on assets | β | 1.5% | 7.7% |
| Return on tangible equity | β21.6% | 0.0% | 5.0% |
| Growth | |||
| Revenue growth | β | 62.7% | 48.7% |
| Net income growth | β | β | 677.6% |
| Share count change | β | 41.6% | 95.2% |
| Financial health | |||
| Debt / equity | β | 1.3x | 0.5x |
| Current ratio | β | 1.4x | 2.2x |
| Quick ratio | β | 1.4x | 2.2x |
| Capital allocation | |||
| Stock comp / revenue | 6.4% | 11.4% | 12.3% |
| Quality scores | |||
| Piotroski F-score | β | β | 5.0 |
| Altman Z'' | β | 0.9 | 4.1 |
| Accruals ratio | β | 12.4% | 4.1% |
Source: SEC EDGAR XBRL filings (CIK 0002064124). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
